I am not sure if the article added more. I will go and take a look out of interest, but nothing new as it seems to be all what Farah mentioned after the FDA news broke. It's good OIL is getting exposure and more potential investors are hearing about the story.
My concert remains though with
"the FDA recommended additional studies to expedite a future DeNovo submission."
I would love Camile to give a timeline update on how long until he believes these studies can be completed for the new submission. Are we talking 6 months or 18 months?
Ann: Optiscan Platform Highly Accurate for Oral Cancer Diagnosis, page-14
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $162.8M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 19.5¢ | $9.825K | 50.38K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10085 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 20733 | 2 |
View Market Depth
| Last trade - 10.36am 08/08/2024 (20 minute delay) ? |
| OIL (ASX) Chart |